thiazoles has been researched along with Mast-Cell Leukemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aichberger, KJ; Gleixner, KV; Kretschmer, A; Sperr, WR; Valent, P | 1 |
Aouba, A; Asnafi, V; Brouze, C; Canioni, D; Chandesris, MO; Dubreuil, P; Feger, F; Georgin-Lavialle, S; Gineste, P; Hanssens, K; Hermine, O; Lepelletier, Y; Letard, S; Lhermitte, L; Macintyre, E; Mansfield, CD; Moussy, A; Renand, A; Suarez, F; Yang, Y | 1 |
2 other study(ies) available for thiazoles and Mast-Cell Leukemia
Article | Year |
---|---|
Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis.
Topics: Aged; Antineoplastic Agents; Cladribine; Dasatinib; Disease Progression; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Leukemia, Mast-Cell; Mastocytosis, Systemic; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Treatment Failure; Tryptases | 2008 |
Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor.
Topics: Aged; Animals; Antineoplastic Agents; Base Sequence; Benzamides; Chlorocebus aethiops; COS Cells; Female; Humans; Immunophenotyping; Leukemia, Mast-Cell; Mast Cells; Mutation; Neoplastic Cells, Circulating; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyridines; Thiazoles; Tryptases | 2012 |